Mohs Micrographic Surgery at IDC 2027

Mohs Micrographic Surgery is an advanced surgical technique used to treat certain types of skin cancer, particularly those with high risk of recurrence or located in cosmetically sensitive areas. Named after its inventor, Dr. Frederic Mohs, this procedure involves systematic removal and examination of thin layers of skin tissue, layer by layer, until no cancer cells are detected under the microscope. Mohs surgery offers high cure rates while preserving as much healthy tissue as possible, making it particularly suitable for tumors on the face, ears, nose, and other delicate areas. The procedure is performed under local anesthesia in an outpatient setting, allowing patients to return home the same day. During Mohs surgery, the surgeon acts as both the surgeon and the pathologist, examining each layer of tissue immediately after removal. This real-time analysis ensures precise removal of cancerous cells while sparing healthy tissue, minimizing scarring and maximizing cosmetic outcomes. After complete removal of the tumor, the surgical site may be left to heal naturally or reconstructed using various techniques such as suturing, skin grafts, or flaps, depending on the size and location of the defect. Mohs Micrographic Surgery is considered the gold standard for treating certain types of skin cancer, including basal cell carcinoma, squamous cell carcinoma, and some forms of melanoma. Its high cure rates and tissue-sparing approach make it a preferred option for many patients and dermatologists worldwide.